Corresponding Author: Adit A. Ginde, MD, MPH, Department of Emergency Medicine, University of Colorado School of Medicine, 12401 E 17th Ave, B-215, Aurora, CO 80045 (adit.ginde@cuanschutz.edu).
Published Online: February 17, 2021. doi:10.1001/jama.2020.26850
Conflict of Interest Disclosures: Dr Leaf is supported by grants from the National Institutes of Heath (R01HL144566 and R01DK125786). Dr Ginde reported receiving grants from the National Institutes of Health (U01HL123010, R01HL544166, R01HL149422, 1OT2HL156812, 3UL1TR002243), the Centers for Disease Control and Prevention (contract 75D30120R67837), and the US Department of Defense (contracts BA190054, MTEC-19-08-MuLTI-0043, JW190515, BA190049, FA8650-20-2-6227) outside the submitted work.
5.Amrein
K , Schnedl
C , Holl
A ,
et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.
JAMA. 2014;312(15):1520-1530. doi:
10.1001/jama.2014.13204PubMedGoogle ScholarCrossref 6.Ginde
AA , Brower
RG , Caterino
JM ,
et al; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early high-dose vitamin D
3 for critically ill, vitamin d-deficient patients.
N Engl J Med. 2019;381(26):2529-2540. doi:
10.1056/NEJMoa1911124PubMedGoogle ScholarCrossref 8.Bischoff-Ferrari
HA , Vellas
B , Rizzoli
R ,
et al; DO-HEALTH Research Group. Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial.
JAMA. 2020;324(18):1855-1868. doi:
10.1001/jama.2020.16909PubMedGoogle ScholarCrossref 9.Okereke
OI , Reynolds
CF
III , Mischoulon
D ,
et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial.
JAMA. 2020;324(5):471-480. doi:
10.1001/jama.2020.10224PubMedGoogle ScholarCrossref 10.Xu
J , Yang
J , Chen
J , Luo
Q , Zhang
Q , Zhang
H . Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system.
Mol Med Rep. 2017;16(5):7432-7438. doi:
10.3892/mmr.2017.7546PubMedGoogle ScholarCrossref 12.Murai
IH , Fernandes
AL , Sales
LP ,
et al. Effect of a single high dose of vitamin D
3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial.
JAMA. Published online February 17, 2021. doi:
10.1001/jama.2020.26848Google Scholar 15.The REMAP-CAP Investigators. Interleukin-6 receptor antagonists in critically ill patients with Covid-19: preliminary report.
MedRxiv. Preprint posted January 7, 2021. doi:
10.1101/2021.01.07.21249390v1. 2021.
17.Lundgren
JD , Grund
B , Barkauskas
CE ,
et al; ACTIV-3/TICO LY-CoV555 Study Group. A neutralizing monoclonal antibody for hospitalized patients with Covid-19.
N Engl J Med. Published online December 22, 2020. doi:
10.1056/NEJMoa2033130PubMedGoogle Scholar 18.Gottlieb
RL , Nirula
A , Chen
P ,
et al. Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial.
JAMA. 2021. doi:
10.1001/jama.2021.0202PubMedGoogle Scholar